VSTM – Verastem Inc.

VSTM — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

23.7

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.05

EPS Last/This Y

1.31

EPS This/Next Y

0.53

Price

5.04

Target Price

16.88

Analyst Recom

Performance Q

-35.96

Upside

-2,412.5%

Beta

0.43

Ticker: VSTM

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	VSTM	5.72	0.13	0.02	8303
2026-03-02	VSTM	5.81	0.13	0.00	8315
2026-03-03	VSTM	5.68	0.13	4.35	8354
2026-03-04	VSTM	5.79	0.14	0.44	8433
2026-03-05	VSTM	6.16	0.08	0.07	13423
2026-03-06	VSTM	6.39	0.08	0.19	13459
2026-03-09	VSTM	6.29	0.08	0.50	13572
2026-03-10	VSTM	6.4	0.08	0.32	13596
2026-03-11	VSTM	6.18	0.09	1.14	13638
2026-03-12	VSTM	5.82	0.09	0.52	13644
2026-03-13	VSTM	5.84	0.09	0.68	13644
2026-03-17	VSTM	5.68	0.08	0.06	13852
2026-03-18	VSTM	5.55	0.08	0.14	13804
2026-03-19	VSTM	5.81	0.08	0.10	13818
2026-03-20	VSTM	5.55	0.08	0.06	14335
2026-03-23	VSTM	5.39	0.04	0.05	7479
2026-03-24	VSTM	4.91	0.04	0.03	7843
2026-03-25	VSTM	5.09	0.04	0.35	9802
2026-03-26	VSTM	5.3	0.04	0.00	9873
2026-03-27	VSTM	5.03	0.04	0.40	10371
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	VSTM	5.72	15.0	-	-2.73
2026-03-02	VSTM	5.80	15.0	123.5	-2.73
2026-03-03	VSTM	5.68	15.0	128.5	-2.73
2026-03-04	VSTM	5.79	15.0	123.4	-2.73
2026-03-05	VSTM	6.16	15.0	117.5	-2.73
2026-03-06	VSTM	6.38	15.0	120.8	-2.73
2026-03-09	VSTM	6.29	40.5	110.4	-1.74
2026-03-10	VSTM	6.40	40.5	105.8	-1.74
2026-03-11	VSTM	6.20	40.5	112.7	-1.74
2026-03-12	VSTM	5.82	40.5	117.0	-1.74
2026-03-13	VSTM	5.60	40.5	114.2	-1.74
2026-03-17	VSTM	5.67	40.9	111.9	-1.71
2026-03-18	VSTM	5.54	40.9	-	-1.71
2026-03-19	VSTM	5.82	40.9	69.0	-1.71
2026-03-20	VSTM	5.55	40.9	85.4	-1.71
2026-03-23	VSTM	5.38	40.9	82.9	-1.71
2026-03-24	VSTM	4.91	40.9	93.3	-1.71
2026-03-25	VSTM	5.09	40.9	71.3	-1.71
2026-03-26	VSTM	5.30	40.9	70.0	-1.71
2026-03-27	VSTM	5.04	40.9	86.3	-1.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	VSTM	-0.68	20.84	27.95
2026-03-02	VSTM	-0.68	21.91	27.95
2026-03-03	VSTM	-0.68	21.91	27.95
2026-03-04	VSTM	-0.68	21.91	27.95
2026-03-05	VSTM	-0.68	21.91	27.95
2026-03-06	VSTM	-0.68	21.91	27.95
2026-03-09	VSTM	-0.58	18.77	27.95
2026-03-10	VSTM	-0.58	18.77	27.95
2026-03-11	VSTM	-0.58	18.77	26.47
2026-03-12	VSTM	-0.58	18.77	22.70
2026-03-13	VSTM	-0.58	18.77	22.70
2026-03-17	VSTM	-0.58	18.77	22.70
2026-03-18	VSTM	-0.58	18.77	22.70
2026-03-19	VSTM	-0.57	18.77	22.70
2026-03-20	VSTM	-0.57	18.77	22.70
2026-03-23	VSTM	-0.57	18.78	22.70
2026-03-24	VSTM	-0.57	18.78	22.70
2026-03-25	VSTM	-0.57	18.78	23.70
2026-03-26	VSTM	-0.57	18.78	23.70
2026-03-27	VSTM	-0.57	18.78	23.70
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.5

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.45

Insider Transactions

-0.57

Institutional Transactions

18.78

Beta

0.43

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.5

Max Drawdown 5-Year %

-96.2

Target Price

16.88

P/E

Forward P/E

PEG

P/S

14.32

P/B

6.85

P/Free Cash Flow

EPS

-3.33

Average EPS Est. Cur. Y

-1.71

EPS Next Y. (Est.)

-1.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-677.59

Relative Volume

0.87

Return on Equity vs Sector %

-393.6

Return on Equity vs Industry %

-377.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.04

EBIT Estimation

86.3

◆ VSTM Healthcare

$5.04

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

37.5

Range 1M

6.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

20/30

Estimates

1/20

Inst/Vol

5/15

Options

7/10

EPS Yr

46.3%

EPS NY

34.8%

52W%

13.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +234.9% upside

Quality

6/30

Valuation

16/30

Growth

15/25

Stability

5/10

LT Trend

4/5

Upside

+234.9%

Quality

Verastem, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 102

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors. The company is involved in clinical studies, including RAMP 301, a randomized global confirmatory trial to evaluate the combination of Avutometinib and Defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer; RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of Avutometinib and in combination with Defactinib; and FRAME, an investigation of Avutometinib and Defactinib in patients with KRAS mutant cancers and subsequent analyses; and RAMP 205. It has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing Avutometinib; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic, and prophylactic uses in humans. In addition, it has a clinical collaboration agreement with Amgen, Inc. to evaluate the combination of Avutometinib with Amgen's KRAS-G12C inhibitor LUMAKRAS, which in Phase 1/2 trial entitled RAMP 203; VS-7375, and VS-7375-101 is a discovery and development collaboration with GenFleet Therapeutics to advance new programs targeting RAS pathway-driven cancers; and AVMAPKI, FAKZYNJA, CO-PACK, is an avutometinib capsules, and defactinib tablets. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts.

VSTM

Latest News

—

Caricamento notizie per VSTM…

stock quote shares VSTM – Verastem Inc. Stock Price stock today

news today VSTM – Verastem Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VSTM – Verastem Inc. yahoo finance google finance

stock history VSTM – Verastem Inc. invest stock market

stock prices VSTM premarket after hours

ticker VSTM fair value insiders trading

VSTM – Verastem, Inc.

VSTM — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

23.7

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.05

EPS Last/This Y

1.31

EPS This/Next Y

0.53

Price

5.04

Target Price

16.88

Analyst Recom

Performance Q

-35.96

Upside

-2,412.5%

Beta

0.43

Ticker: VSTM

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	VSTM	5.72	0.13	0.02	8303
2026-03-02	VSTM	5.81	0.13	0.00	8315
2026-03-03	VSTM	5.68	0.13	4.35	8354
2026-03-04	VSTM	5.79	0.14	0.44	8433
2026-03-05	VSTM	6.16	0.08	0.07	13423
2026-03-06	VSTM	6.39	0.08	0.19	13459
2026-03-09	VSTM	6.29	0.08	0.50	13572
2026-03-10	VSTM	6.4	0.08	0.32	13596
2026-03-11	VSTM	6.18	0.09	1.14	13638
2026-03-12	VSTM	5.82	0.09	0.52	13644
2026-03-13	VSTM	5.84	0.09	0.68	13644
2026-03-17	VSTM	5.68	0.08	0.06	13852
2026-03-18	VSTM	5.55	0.08	0.14	13804
2026-03-19	VSTM	5.81	0.08	0.10	13818
2026-03-20	VSTM	5.55	0.08	0.06	14335
2026-03-23	VSTM	5.39	0.04	0.05	7479
2026-03-24	VSTM	4.91	0.04	0.03	7843
2026-03-25	VSTM	5.09	0.04	0.35	9802
2026-03-26	VSTM	5.3	0.04	0.00	9873
2026-03-27	VSTM	5.03	0.04	0.40	10371
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	VSTM	5.72	15.0	-	-2.73
2026-03-02	VSTM	5.80	15.0	123.5	-2.73
2026-03-03	VSTM	5.68	15.0	128.5	-2.73
2026-03-04	VSTM	5.79	15.0	123.4	-2.73
2026-03-05	VSTM	6.16	15.0	117.5	-2.73
2026-03-06	VSTM	6.38	15.0	120.8	-2.73
2026-03-09	VSTM	6.29	40.5	110.4	-1.74
2026-03-10	VSTM	6.40	40.5	105.8	-1.74
2026-03-11	VSTM	6.20	40.5	112.7	-1.74
2026-03-12	VSTM	5.82	40.5	117.0	-1.74
2026-03-13	VSTM	5.60	40.5	114.2	-1.74
2026-03-17	VSTM	5.67	40.9	111.9	-1.71
2026-03-18	VSTM	5.54	40.9	-	-1.71
2026-03-19	VSTM	5.82	40.9	69.0	-1.71
2026-03-20	VSTM	5.55	40.9	85.4	-1.71
2026-03-23	VSTM	5.38	40.9	82.9	-1.71
2026-03-24	VSTM	4.91	40.9	93.3	-1.71
2026-03-25	VSTM	5.09	40.9	71.3	-1.71
2026-03-26	VSTM	5.30	40.9	70.0	-1.71
2026-03-27	VSTM	5.04	40.9	86.3	-1.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	VSTM	-0.68	20.84	27.95
2026-03-02	VSTM	-0.68	21.91	27.95
2026-03-03	VSTM	-0.68	21.91	27.95
2026-03-04	VSTM	-0.68	21.91	27.95
2026-03-05	VSTM	-0.68	21.91	27.95
2026-03-06	VSTM	-0.68	21.91	27.95
2026-03-09	VSTM	-0.58	18.77	27.95
2026-03-10	VSTM	-0.58	18.77	27.95
2026-03-11	VSTM	-0.58	18.77	26.47
2026-03-12	VSTM	-0.58	18.77	22.70
2026-03-13	VSTM	-0.58	18.77	22.70
2026-03-17	VSTM	-0.58	18.77	22.70
2026-03-18	VSTM	-0.58	18.77	22.70
2026-03-19	VSTM	-0.57	18.77	22.70
2026-03-20	VSTM	-0.57	18.77	22.70
2026-03-23	VSTM	-0.57	18.78	22.70
2026-03-24	VSTM	-0.57	18.78	22.70
2026-03-25	VSTM	-0.57	18.78	23.70
2026-03-26	VSTM	-0.57	18.78	23.70
2026-03-27	VSTM	-0.57	18.78	23.70
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.5

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.45

Insider Transactions

-0.57

Institutional Transactions

18.78

Beta

0.43

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.5

Max Drawdown 5-Year %

-96.2

Target Price

16.88

P/E

Forward P/E

PEG

P/S

14.32

P/B

6.85

P/Free Cash Flow

EPS

-3.33

Average EPS Est. Cur. Y

-1.71

EPS Next Y. (Est.)

-1.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-677.59

Relative Volume

0.87

Return on Equity vs Sector %

-393.6

Return on Equity vs Industry %

-377.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.04

EBIT Estimation

86.3

◆ VSTM Healthcare

$5.04

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

37.5

Range 1M

6.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

20/30

Estimates

1/20

Inst/Vol

5/15

Options

7/10

EPS Yr

46.3%

EPS NY

34.8%

52W%

13.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +234.9% upside

Quality

6/30

Valuation

16/30

Growth

15/25

Stability

5/10

LT Trend

4/5

Upside

+234.9%

Quality

Verastem, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 102

VSTM

Latest News

—

Caricamento notizie per VSTM…

stock quote shares VSTM – Verastem, Inc. Stock Price stock today

news today VSTM – Verastem, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VSTM – Verastem, Inc. yahoo finance google finance

stock history VSTM – Verastem, Inc. invest stock market

stock prices VSTM premarket after hours

ticker VSTM fair value insiders trading

VSTM – Verastem Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VSTM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

VSTM – Verastem, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VSTM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y